SmartMetric (SMME) 10-Q 14 Nov 19 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Sep. 30, 2019	Nov. 14, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	SmartMetric, Inc.
Entity Central Index Key	0001301991
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Interactive Data Current	No
Entity File Number	000-54853
Entity Incorporation State Country Code	NV
Entity Common Stock, Shares Outstanding		278,357,626

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2019	Jun. 30, 2019
Current assets:
Cash		$ 10,161
Prepaid expenses and other current assets	14,017	6,450
Total current assets	14,017	16,611
Total assets	14,017	16,611
Current liabilities:
Accounts payable and accrued expenses	886,383	880,390
Liability for stock to be issued	54,979	147,484
Deferred Officer's salary	790,015	790,015
Related party interest payable	107,313	93,488
Dividends payable	1,862	3,123
Credit card payable	7,839	3,750
Shareholder loan	14,059	3,759
Total current liabilities	1,862,450	1,922,009
Series C mandatory redeemable convertible preferred stock, net of discount, authorized 1,000,000 shares 104,500 and 121,700 shares issued and outstanding, respectively	90,751	99,278
Stockholders' deficit:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding	610	610
Common stock, $.001 par value; 300,000,000 shares authorized, 275,865,126 and 264,648,821 shares issued and outstanding , respectively	275,865	264,649
Additional paid-in capital	24,944,825	24,663,528
Accumulated deficit	(27,160,484)	(26,933,463)
Total stockholders' deficit	(1,939,184)	(2,004,676)
Total liabilities and stockholders' deficit	$ 14,017	$ 16,611

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - $ / shares	Sep. 30, 2019	Jun. 30, 2019
Preferred stock, par value	$ .001	$ .001
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	610,000	610,000
Preferred stock, outstanding	610,000	610,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	300,000,000	300,000,000
Common stock, issued	275,865,126	264,648,821
Common stock, outstanding	275,865,126	264,648,821
Series C mandatory redeemable convertible preferred stock
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, issued	104,500	121,700
Preferred stock, outstanding	104,500	121,700

Condensed Consolidated Statemen

Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Revenues
Expenses:
Officer's salary	47,500	47,500
Other general and administrative	132,859	124,004
Research and development	21,112	29,360
Total operating expenses	201,471	200,864
Loss from operations before other expense	(201,471)	(200,864)
Other expense
Interest expense	(13,825)	(12,463)
Total other expense	(13,825)	(12,463)
Loss before income taxes	(215,296)	(213,327)
Provision for income taxes
Net loss	(215,296)	(213,327)
Preferred stock dividends	(11,725)
Net loss available for common stockholders	$ (227,021)	$ (213,327)
Net loss per share, basic and diluted	$ 0	$ 0
Weighted average number of common shares outstanding, basic and diluted	272,691,261	250,262,593

Consolidated Statements of Chan

Consolidated Statements of Changes In Stockholders' (Deficit) (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Class A Common Stock	Total
Balance at Jun. 30, 2018	$ 610	$ 249,148	$ 24,217,831	$ (25,996,910)		$ (1,529,321)
Balance, Shares at Jun. 30, 2018	610,000	249,147,547
Shares issued of common stock and warrants for cash		$ 5,502	210,667			216,169
Shares issued of common stock and warrants for cash, shares		5,502,538
Net loss for the period				(213,827)		(213,327)
Balance at Sep. 30, 2018	$ 610	$ 254,650	24,428,498	(26,210,737)		(1,526,979)
Balance, shares at Sep. 30, 2018	610,000	254,650,085
Balance at Jun. 30, 2019	$ 610	$ 264,649	24,663,528	(26,933,461)		(2,004,676)
Balance, Shares at Jun. 30, 2019	610,000	264,648,821
Shares issued of common stock and warrants for cash		$ 7,992	218,008			226,000
Shares converted from Preferred shares		$ 3,224	63,289			66,513
Shares converted from Preferred shares, shares		3,224,643
Shares issued of common stock and warrants for cash, shares		7,991,662
Preferred Dividends				(11,725)		(11,725)
Net loss for the period				(215,296)		(215,296)
Balance at Sep. 30, 2019	$ 610	$ 275,865	$ 24,944,825	$ (27,160,482)		$ (1,939,184)
Balance, shares at Sep. 30, 2019	610,000	275,865,126

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (215,296)	$ (213,327)
Changes in assets and liabilities
Decrease in prepaid expenses and other current assets	(7,567)	2,500
(Decrease) increase in accounts payable and accrued expenses	5,993	7,726
Increase in deferred officer salary		47,500
Increase (decrease) in credit card debt	4,089	1,120
Increase (decrease) in dividends payable	(1,261)
Increase in accrued interest payable	13,825	12,463
Net cash used in operating activities	(200,217)	(142,018)
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties	10,300	3,000
Proceeds from sale of common stock	133,495	145,770
Proceeds from sale of series C preferred stock	45,000
Dividend payable	1,261
Net cash provided by financing activities	190,056	148,770
CASH BEGINNING OF PERIOD	10,161	4,427
END OF PERIOD		11,179
CASH PAID DURING THE PERIOD FOR:
Income taxes
Interest

Organization and Basis of Prese

Organization and Basis of Presentation	3 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 ORGANIZATION AND BASIS OF PRESENTATION SmartMetric, Inc. ("SmartMetric" or the "Company") was incorporated pursuant to the laws of Nevada on December 18, 2002. SmartMetric is a company engaged in the technology industry. SmartMetric's main products are a fingerprint sensor activated payments card and a security card with a finger sensor and fully functional fingerprint reader embedded inside the card. The SmartMetric biometric cards have a rechargeable battery allowing for portable biometric identification and card activation. This card is referred to as a biometric card or the SmartMetric Biometric Card. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management of the Company, the accompanying unaudited financial statements contain all the adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the three months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. For further information, refer to the financial statements and the footnotes thereto contained in the Company's Annual Report on Form 10-K for the year ended June 30, 2019, as filed with the Securities and Exchange Commission on September 30, 2019. The condensed consolidated balance sheet as of June 30, 2019, has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by US GAAP for complete financial statements. Going Concern As shown in the accompanying condensed consolidated financial statements the Company has sustained recurring losses of $215,296 and $213,327 for the three months ended September 30, 2019 and 2018, respectively, and has an accumulated deficit of $27,160,484 at September 30, 2019. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company's working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern beyond November 2020. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management believes that the Company's capital requirements will depend on many factors. These factors include product marketing and distribution. The management plans include equity sales and borrowing in order to fund the operations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The condensed consolidated financial statements do not include any adjustments relating to the carrying amounts of recorded assets or the carrying amounts and classification of recorded liabilities that may be required should the Company be unable to continue as a going concern. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Actual results may differ from those estimates. Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs. Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company's results of operations, financial position or cash flow except as noted below. In February 2016, the FASB issued authoritative guidance, which is included in ASC 842, "Leases." This guidance requires lessees to recognize most leases on the balance sheet by recording a right-of-use asset and a lease liability. The Company has made the decision to adopt this guidance early, making it effective for the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment did not have a material impact on the financial statements. In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity—Equity-Based Payments to Non-Employees. This guidance is effective for the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment did not have a material impact on the financial statements. Loss Per Share of Common Stock In accordance with FASB ASC 260, "Earnings Per Share," the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2019 and 2018, 29,403,406 and 17,488,656 dilutive shares were excluded from the calculation of diluted loss per common share.

Prepaid Expenses

Prepaid Expenses	3 Months Ended
	Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSES	NOTE 3 PREPAID EXPENSES Prepaid expenses represent the unexpired terms of various consulting agreements as well as advance rental payments. The Company does not currently have any prepaid items related to shares issued for services.

Commitments

Commitments	3 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 4 - COMMITMENTS Lease Agreement The Company's main office is located in Las Vegas, Nevada. Rent expense under all leases for the three months ended September 30, 2019 and 2018 was $1,166 and $3,349 respectively. The Company maintains only one office. This office is located in Las Vegas, NV and is a month-to-month lease. Related Party Transactions The Company's Chief Executive Officer has made cash advances to the Company with an aggregate amount due of $14,059 and $3,759 at September 30, 2019 and June 30, 2019, respectively. These advances bear interest at the rate of seven percent (7%) per annum. The Company has accrued the amounts of $790,015 and $790,015 at September 30, 2019 and June 30, 2019, respectively, as deferred officer's salary, for the difference between the Chief Executive Officer's annual salary and the amounts paid. On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares.

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Sep. 30, 2019
Equity [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 5 STOCKHOLDERS' DEFICIT Preferred Stock As of September 30, 2019, the Company had 5,000,000 shares of Class B preferred stock, par value $0.001, authorized and 610,000 shares issued and outstanding. On December 11, 2009, the Company filed a Certificate of Designation with the State of Nevada, to designate 500,000 shares of preferred stock as Series B Convertible Preferred Stock ("Series B Convertible Preferred Stock"). Effective November 5, 2014, the number of shares designated as Series C Convertible Preferred Stock was increased to 1,000,000 shares. Each share of Series B Convertible Preferred Stock has a par value of $0.001, and a stated value equal to $5.00 ("Stated Value"). Holders of the Series B Convertible Preferred Stock are entitled to receive dividends or other distributions with the holders of the common stock of the Company on an as converted basis when, as, and if declared by the directors of the Company. Holders of the Series B Convertible Preferred Stock are entitled to convert each share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock. Common Stock As of September 30, 2019, the Company had 275,865,126 shares of common stock issued and outstanding. ● During the three months ended September 30, 2019, the Company sold for cash 6,337,500 shares of common stock and warrants to purchase: (i) 6,337,500 shares at prices ranging from $0.10 per share to $0.25 per share for net proceeds of $133,495. The warrants expire at various times through September 17, 2021. None of these shares were issued during the quarter ended September 30, 2019, with all 6,337,500 shares being recorded as stock payable. During the three months ended September 30, 2019, the Company issued 11,216,305 shares for cash. Of these shares, 7,991,662 were issued from stock payable and 3,224,643 were converted from Preferred shares. ● During the three months ended September 30, 2018, the Company sold for cash 4,624,153 shares of common stock for net proceeds of $145,770 and warrants to purchase (i) 3,699,988 shares at $0.25, (ii) 60,000 shares at $0.30, (iii) 30,000 shares at $0.50, (iv) 301,875 shares at $0.70 and (v) 151,970 shares at $1.00. During the quarter ended September 30, 2018, the Company issued a total of 5,502,538 shares of common stock. Of the total number of shares issued, 3,061,659 shares were for proceeds received during the quarter and 2,440,879 shares to reduce the liability for stock to be issued. Warrants From time to time the Company granted warrants in connection with private placements of securities, as described herein. As of September 30, 2019, and June 30, 2019, the following is a breakdown of the warrant activity: Range of Exercise Prices Number of Warrants Outstanding Weighted- Weighted- Number Exercisable Weighted- $0.05 - $1.00 32,863,734 1.26 $ 0.28 32,863,734 $ 0.28 Warrants Outstanding and Exercisable at June 30, 2019: $0.20 - $1.00 26,526,234 1.12 $ 0.34 26,526,234 $ 0.34 Warrant Activity: September 30, 2019: Outstanding - June 30, 2019 26,526,234 Issued 6,337,500 Exercised — Expired (3,460,328 ) Outstanding - September 30, 2019 29,403,406 June 30, 2019: Outstanding - June 30, 2018 14,842,583 Issued 18,738,235 Exercised — Expired (7,054,584 ) Outstanding - June 30, 2019 26,526,234 At September 30, 2019, all of the 29,403,406 warrants are vested and (i) 29,103,406 warrants expire at various times prior to September 17, 2021, (ii) 300,000 warrants expire in July 2020,

Mandatory Redeemable Convertibl

Mandatory Redeemable Convertible Preferred Stock	3 Months Ended
	Sep. 30, 2019
Mandatory Redeemable Convertible Preferred Stock [Abstract]
MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	NOTE 6 MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK Issuances of Series C Mandatory Redeemable Convertible Preferred Stock On January 10, 2019, the Board of Directors of the Company adopted a resolution pursuant to the Company's Certificate of Incorporation, as amended, providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations and restrictions, of the Series C Convertible Preferred Stock. On January 14, 2019, the Company filed a Certificate of Designations for a Series C Convertible Preferred Stock. The authorized number of Series C Convertible Preferred Stock is 1,000,000 shares, par value 0.001. The Series C Preferred Stock will, with respect to dividend rights and rights upon liquidation, winding-up or dissolution, rank: (a) senior with respect to dividends and right of The number of Series C, mandatory redeemable convertible preferred stock shares issued and outstanding were 104,500 and 121,700, respectively, for September 30, 2019 and June 30, 2019. The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The "Variable Conversion Price" shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). "Market Price" means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. On the date which is eighteen (18) months following the Issuance Date or upon the occurrence of an Event of Default (the "Mandatory Redemption Date"), the Company shall redeem all of the shares of Series C Preferred Stock of the Holder (which have not been previously redeemed or converted). With five (5) days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to the total number of shares of Series C Preferred Stock held by such Holder multiplied by the then current Stated Value. All shares of mandatorily redeemable convertible preferred stock have been presented outside of permanent equity in accordance with ASC 480, Classification and Measurement of Redeemable Securities The estimated fair value of the Series C mandatory redeemable convertible preferred stock at September 30, 2019 and 2018 was $90,751 and $0, respectively.

Income Taxes

Income Taxes	3 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 7 INCOME TAXES The Company provides for income taxes at the end of each interim period based on the estimated effective tax rate for the full fiscal year. Cumulative adjustments to the Company's estimate are recorded in the interim period in which a change in the estimated annual effective rate is determined. The Company has estimated its effective tax rate to be 0%, based primarily on losses incurred and the uncertainty of realization of the tax benefit of such losses.

Litigation

Litigation	3 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	NOTE 8 LITIGATION From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. As of the date of this Quarterly Report, there are no material pending legal or governmental proceedings relating to us or properties to which we are a party, and, to our knowledge, there are no material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us. Commitments and Contingencies

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has analyzed its operations subsequent to September 30, 2019 to the date these financial statements were issued. Subsequent to September 30, 2019, the Company issued 2,492,500 common stock shares, all of which attributable to stock payable.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements do not include any adjustments relating to the carrying amounts of recorded assets or the carrying amounts and classification of recorded liabilities that may be required should the Company be unable to continue as a going concern.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Actual results may differ from those estimates.
Research and Development	Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs.
Loss Per Share of Common Stock	Loss Per Share of Common Stock In accordance with FASB ASC 260, "Earnings Per Share," the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of September 30, 2019 and 2018, 29,403,406 and 17,488,656 dilutive shares were excluded from the calculation of diluted loss per common share.

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	3 Months Ended
	Sep. 30, 2019
Stockholders' Equity Note [Abstract]
Schedule of share based compensation warrant activity	Range of Exercise Prices Number of Warrants Outstanding Weighted- Weighted- Number Exercisable Weighted- $0.05 - $1.00 32,863,734 1.26 $ 0.28 32,863,734 $ 0.28 Warrants Outstanding and Exercisable at June 30, 2019: $0.20 - $1.00 26,526,234 1.12 $ 0.34 26,526,234 $ 0.34 Warrant Activity: September 30, 2019: Outstanding - June 30, 2019 26,526,234 Issued 6,337,500 Exercised — Expired (3,460,328 ) Outstanding - September 30, 2019 29,403,406 June 30, 2019: Outstanding - June 30, 2018 14,842,583 Issued 18,738,235 Exercised — Expired (7,054,584 ) Outstanding - June 30, 2019 26,526,234

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) - USD ($)	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019
Organization and Basis of Presentation (Textual)
Net loss	$ (215,296)	$ (213,327)
Accumulated deficit	$ (27,160,484)	$ 27,160,484	$ (26,933,463)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - shares	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Summary of Significant Accounting Policies (Textual)
Dilutive shares were excluded from diluted loss per common share	29,403,406	17,488,656

Commitments (Details)

Commitments (Details) - USD ($)	Sep. 11, 2019	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019
Commitments (Textual)
Rent expense		$ 1,166	$ 3,349
Deferred compensation liability		790,015		$ 790,015
Chief Executive Officer [Member]
Commitments (Textual)
Cash advances from related party		$ 14,059		$ 3,759
Interest rate		7.00%
Related party transactions, description	(i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares.

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - Warrant [Member] - shares	3 Months Ended	12 Months Ended
	Sep. 30, 2019	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding - beginning of year	26,526,234	14,842,583
Issued	6,337,500	18,738,235
Exercised
Expired	(3,460,328)	(7,054,584)
Outstanding - end of year	29,403,406	26,526,234

Stockholders' Deficit (Details

Stockholders' Deficit (Details 1) - Warrant [Member] - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Sep. 30, 2018
$0.05 - $1.00 [Member]
Warrants Outstanding and Exercisable
Number of Warrants Outstanding		26,526,234
Weighted-Average Contractual Life Remining in Years	1 year 3 months 4 days	1 year 1 month 13 days
Weighted-average exercise price		$ 0.34
Number Exercisable		26,526,234
$0.05 - $1.00 [Member] | Minimum [Member]
Warrants Outstanding and Exercisable
Exercise Price		$ 0.20
$0.05 - $1.00 [Member] | Maximum [Member]
Warrants Outstanding and Exercisable
Exercise Price		$ 1
$0.20 - $1.00 [Member]
Warrants Outstanding and Exercisable
Number of Warrants Outstanding			32,863,734
Weighted-average exercise price			$ 0.28
Number Exercisable			32,863,734
$0.20 - $1.00 [Member] | Minimum [Member]
Warrants Outstanding and Exercisable
Exercise Price			$ 0.05
$0.20 - $1.00 [Member] | Maximum [Member]
Warrants Outstanding and Exercisable
Exercise Price			$ 1

Stockholders' Deficit (Detail_2

Stockholders' Deficit (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019
Stockholders' Deficit (Textual)
Preferred stock, shares authorized	5,000,000		5,000,000
Preferred stock, par value	$ .001		$ .001
Preferred stock, shares issued	610,000		610,000
Preferred stock, shares outstanding	610,000		610,000
Common stock, par value	$ 0.001		$ 0.001
Common stock, shares authorized	300,000,000		300,000,000
Common stock, shares issued	275,865,126		264,648,821
Common stock, shares outstanding	275,865,126		264,648,821
Shares of common stock sold for cash	6,337,500	4,624,153
Common stock for net proceeds	$ 133,495	$ 145,770
Warrants to purchase shares, description	Warrants to purchase: (i) 6,337,500 shares at prices ranging from $0.10 per share to $0.25 per share for net proceeds of $133,495. The warrants expire at various times through September 17, 2021. None of these shares were issued during the quarter ended September 30, 2019, with all 6,337,500 shares being recorded as stock payable.  During the three months ended September 30, 2019, the Company issued 11,216,305 shares for cash.  Of these shares, 7,991,662 were issued from stock payable and 3,224,643 were converted from Preferred shares.	Net proceeds of $145,770 and warrants to purchase (i) 3,699,988 shares at $0.25, (ii) 60,000 shares at $0.30, (iii) 30,000 shares at $0.50, (iv) 301,875 shares at $0.70 and (v) 151,970 shares at $1.00.  During the quarter ended September 30, 2018, the Company issued a total of 5,502,538 shares of common stock.  Of the total number of shares issued, 3,061,659 shares were for proceeds received during the quarter and 2,440,879 shares to reduce the liability for stock to be issued.
Warrant [Member]
Stockholders' Deficit (Textual)
Number of warrants vested	29,403,406
Warrants expire	Sep. 17, 2021
Number of warrants	$ 29,103,406
Warrant One [Member]
Stockholders' Deficit (Textual)
Warrants expire	Jul. 31, 2020
Number of warrants	$ 300,000
Class B preferred stock [Member]
Stockholders' Deficit (Textual)
Preferred stock, shares authorized	5,000,000
Preferred stock, par value	$ 0.001
Preferred stock, shares issued	610,000
Preferred stock, shares outstanding	610,000
Class A Common Stock
Stockholders' Deficit (Textual)
Common stock, par value	$ 0.001
Common stock, shares authorized	50,000,000
Common stock, shares issued
Common stock, shares outstanding

Mandatory Redeemable Converti_2

Mandatory Redeemable Convertible Preferred Stock (Details) - USD ($)	Jan. 14, 2019	Sep. 30, 2019	Jun. 30, 2019	Jun. 30, 2018
Preferred stock, authorized		5,000,000	5,000,000
Preferred stock, par value		$ .001	$ .001
Preferred stock shares issued		610,000	610,000
Preferred stock shares outstanding		610,000	610,000
Accretion		$ 2,252
Series C mandatory redeemable convertible preferred stock [Member]
Fair value of convertible preferred stock		$ 90,751		$ 0
Preferred stock, authorized	1,000,000
Preferred stock, par value	$ 0.001
Dividend percent	10.00%
Description of conversion of stock		The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date.
Preferred stock shares issued		104,500	121,700
Preferred stock shares outstanding		104,500	121,700
Series C mandatory redeemable convertible preferred stock [Member] | Minimum [Member]
Dividend percent	105.00%
Series C mandatory redeemable convertible preferred stock [Member] | Maximum [Member]
Dividend percent	130.00%

Subsequent Events (Details)

Subsequent Events (Details) - $ / shares	Nov. 06, 2019	Sep. 30, 2019	Jun. 30, 2019
Subsequent Event (Textual)
Shares of common stock issued		275,865,126	264,648,821
Common stock par value		$ 0.001	$ 0.001
Subsequent Event [Member]
Subsequent Event (Textual)
Shares of common stock issued	2,492,500